Safety and effectiveness of mirabegron in patients ≥75 yrs with overactive bladder: analysis of a Japanese post-marketing commitment study

Research Type

Clinical

Abstract Category

Overactive Bladder

Links
	Abstract 640
	Open Discussion ePosters 3 Scientific Open Discussion Session 35
	Friday 15th September 2017
	13:35 - 13:40 (ePoster Station 6)
	Exhibition Hall
	Overactive Bladder Gerontology Quality of Life (QoL) Questionnaire
	1. Department of Urology, National Center for Geriatrics and Gerontology, Obu, Aichi, Japan, 2. Astellas Pharma Inc, Tokyo, Japan
Presenter
M Masaki Yoshida Department of Urology, National Center for Geriatrics and Gerontology, Obu, Aichi, Japan
Abstract PDF ePoster PDF Edit Abstract Abstract Centre